OBJECTIVES: To assess the prevalence of speech and swallowing impairment after radical surgery for oral and oropharyngeal cancer from the patient's viewpoint and to examine the association of these functional alterations with selected clinical characteristics regarding patients, tumors, and oncologic treatment. DESIGN: Cross-sectional, multicenter study using a self-administered questionnaire. SETTING: Forty-three hospitals in Germany, Switzerland, and Austria. PATIENTS: A total of 3894 questionnaires about rehabilitation problems after treatment for oral and oropharyngeal squamous cell carcinoma were sent to patients. Of these, 1652 were filled out and returned, and 1334 (80.8%) met the inclusion criteria. MAIN OUTCOME MEASURES: Morbidity associated with treatment of oral and oropharyngeal cancer. RESULTS: Speech problems were reported by 851 patients (63.8%), and swallowing problems were reported by 1006 patients (75.4%). The variables that presented a significant association with speech and swallowing impairment were sex, tumor location, pTNM stages, stage of tumor, treatment modality, and reconstruction type. CONCLUSIONS: This survey, based on patient perception, suggests that those who undergo radiotherapy associated with the surgical removal of a tumor, have late-stage tumors (III-IV), or have tumors located in the floor of the mouth should be informed of the greater risk of persistent severe speech and swallowing problems.
OBJECTIVES: To assess the prevalence of speech and swallowing impairment after radical surgery for oral and oropharyngeal cancer from the patient's viewpoint and to examine the association of these functional alterations with selected clinical characteristics regarding patients, tumors, and oncologic treatment. DESIGN: Cross-sectional, multicenter study using a self-administered questionnaire. SETTING: Forty-three hospitals in Germany, Switzerland, and Austria. PATIENTS: A total of 3894 questionnaires about rehabilitation problems after treatment for oral and oropharyngeal squamous cell carcinoma were sent to patients. Of these, 1652 were filled out and returned, and 1334 (80.8%) met the inclusion criteria. MAIN OUTCOME MEASURES: Morbidity associated with treatment of oral and oropharyngeal cancer. RESULTS: Speech problems were reported by 851 patients (63.8%), and swallowing problems were reported by 1006 patients (75.4%). The variables that presented a significant association with speech and swallowing impairment were sex, tumor location, pTNM stages, stage of tumor, treatment modality, and reconstruction type. CONCLUSIONS: This survey, based on patient perception, suggests that those who undergo radiotherapy associated with the surgical removal of a tumor, have late-stage tumors (III-IV), or have tumors located in the floor of the mouth should be informed of the greater risk of persistent severe speech and swallowing problems.
Authors: Raghav C Dwivedi; Edward J Chisholm; Afroze S Khan; Nicholas J Harris; Shree A Bhide; Suzanne St Rose; Cyrus J Kerawala; Peter M Clarke; Christopher M Nutting; Peter H Rhys-Evans; Kevin J Harrington; Rehan Kazi Journal: Eur Arch Otorhinolaryngol Date: 2011-09-10 Impact factor: 2.503
Authors: Raghav C Dwivedi; Suzanne St Rose; Edward J Chisholm; Christos Georgalas; Brian Bisase; Furrat Amen; Cyrus J Kerawala; Peter M Clarke; Christopher M Nutting; Peter H Rhys-Evans; Kevin J Harrington; Rehan Kazi Journal: Dysphagia Date: 2012-02-21 Impact factor: 3.438
Authors: Benedicta E Beck-Broichsitter; Jörn Huck; Thomas Küchler; Daniela Hauke; Jürgen Hedderich; Jörg Wiltfang; Stephan T Becker Journal: J Cancer Res Clin Oncol Date: 2016-10-18 Impact factor: 4.553
Authors: Nogah Nativ-Zeltzer; Maggie A Kuhn; Lisa Evangelista; Johnathon D Anderson; Jan A Nolta; D Gregory Farwell; Emanuele Canestrari; Ron J Jankowski; Peter C Belafsky Journal: Laryngoscope Date: 2021-05-14 Impact factor: 3.325